LOGIN  |  REGISTER
Cue Biopharma

Indivior to Participate in Upcoming Investor Events

August 20, 2025 | Last Trade: US$24.48 0.21 -0.85

RICHMOND, Va., Aug. 20, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the following investor events:

  • Morgan Stanley 23rd Annual Global Healthcare Conference – New York City, NY

    Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Monday, September 8th. Joe Ciaffoni will also participate in a fireside discussion on Monday, September 8th at 9:15 a.m. U.S. ET. Interested investors should contact their Morgan Stanley representative to schedule a meeting. The fireside discussion will be publicly available and can be viewed using the following weblink: Morgan Stanley Webcast Link
  • H.C. Wainwright 27th Annual Global Investment Conference – New York City, NY

    Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Tuesday, September 9th. Interested investors should contact their H.C. Wainwright representative to schedule a meeting.

About Indivior

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients around the world will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in the United States in Richmond, VA, Indivior employs over 1,000 individuals globally and its portfolio of products is available in over 30 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior

Assertio

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page